Clay Thorp, Director, 10% Owner at PhaseBio Pharmaceuticals Inc (PHAS), bought 450,612 shares at $5.00 ($1.5M) on 2018-10-22, disclosed to the SEC on 2018-10-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 150,612 | $0 | 0.0% |
| 2 | $5.00 | 12,487 | $62K | 4.2% |
| 3 | $5.00 | 137,513 | $688K | 45.8% |
| 4 | $5.00 | 150,000 | $750K | 50.0% |
| Total | $3.33 avg | 450,612 | $1.5M | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |